Alector, Inc. Share Price

Alector, Inc. Share Price

NASDAQ: ALEC | Micro Cap
$2.19
-$0.05 (-2.01%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alector, Inc. Stock Performance

Open
$2.19
Prev. Close
$2.24
Circuit Range
N/A
Day Range
$2.10 - $2.24
Year Range
$1.09 - $2.75
Volume
79,922
Average Traded
$2.17

Alector, Inc. Share Price Today

As of 31 October 2026, Alector, Inc.'s share price is $2.19. The stock opened at $2.19, compared to its previous close of $2.24. During today's trading session, Alector, Inc.'s share price traded between $2.10 and $2.24, with an average price of $2.17. Over the past 52 weeks, the stock has recorded a high of $2.75 and a low of $1.09. In terms of performance, Alector, Inc.'s share price has declined by 7.77% over the last six months and is up 48.81% on a year-on-year basis.

Alector, Inc. Share Price Chart

Line chart of the Alector, Inc. price trend over the selected period. The price fell overall, ranging from 2.10 to 2.25, ending at 2.19.
$2.10$2.24
L
Show Current Price
H

Alector, Inc. Stock Fundamentals & Key Indicators

Market Cap
$226.08M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$21.05B
Return On Equity (TTM)
1184.79%
Profit Margin
-679.00%
Debt to Equity
-0.99
Quarterly Earnings Growth YoY
33.69%

Alector, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.26$6.24$1.05$3.32
Net Profit-$34.67-$37.27-$23.20-$22.99
Net Profit Margin-1063.50%-597.28%-2209.52%-692.47%
Income ChangeN/A-7.50%37.75%0.91%

Alector, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$133.62$97.06$100.56$21.05
Net Profit-$133.31-$130.39-$119.05-$142.93
Net Profit Margin-99.77%-134.34%-118.39%-679.00%
Income ChangeN/A2.19%8.70%-20.06%

About Alector, Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Alector, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.81
$2.21
+19.19%
Sep 2026
$2.23
$1.85
-22.59%
Aug 2026
$1.48
$2.39
+58.28%
Jul 2026
$2.02
$1.51
-24.69%
Jun 2026
$2.13
$2.00
-7.60%
May 2026
$2.35
$2.17
-8.82%
Apr 2026
$2.20
$2.38
+10.70%
Mar 2026
$2.33
$2.15
-12.42%
Feb 2026
$1.84
$2.46
+29.21%
Jan 2026
$1.58
$1.90
+21.79%
Dec 2025
$1.28
$1.56
+17.29%
Nov 2025
$1.50
$1.33
-9.83%

ALEC Share Price FAQs